MMD Names Vice President of Regulatory Affairs Medpace Inc. has named Mike Winegar vice president

MMD Names Vice President of Regulatory Affairs

Medpace Inc. has named Mike Winegar vice president of regulatory affairs for subsidiary Medpace Medical Device (MMD).

Winegar brings 25 years of experience to the role. His focuses have been global regulatory affairs, regulatory compliance, quality assurance and clinical research, with a particular emphasis on cardiovascular, neurovascular, and peripheral vascular technologies. He also has held senior leadership positions with several large and small medical device companies.

“Mike Winegar is a highly valued research professional and seasoned industry expert in regulatory affairs, clinical research, and quality assurance,” said Ryan Wilson, general manager, MMD. “His extensive experience in the regulatory and clinical aspects of conducting medical device trials both within and outside of the United States, especially within the cardiac and vascular device arenas, further strengthens MMD’s position as a top tier clinical research organization for the medical device industry. The addition of Mike to the MMD team will allow us to offer deeper strategic solutions for global premarket and post-market clinical and regulatory challenges, including leading clients through changing European and U.S. regulatory approval requirements.”

Medpace and MMD are headquartered in Cincinnati, Ohio, and Minneapolis, Minn., respectively. MMD is a full service medical device contract research organization that offers trial design, project management, site management, monitoring, biostatistics, regulatory support, and data management to customers.